 | • レポートコード：B-GIR08C5393 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ソラフェニブの世界市場について調べ、まとめました。種類別セグメントは、カプセル、タブレット等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。ソラフェニブの世界市場概観、企業動向、企業別ソラフェニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ソラフェニブの市場概観 ・ソラフェニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ソラフェニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ソラフェニブの世界市場規模 ・ソラフェニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ソラフェニブのアメリカ市場規模推移 ・ソラフェニブのカナダ市場規模推移 ・ソラフェニブのメキシコ市場規模推移 ・ソラフェニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ソラフェニブのドイツ市場規模推移 ・ソラフェニブのイギリス市場規模推移 ・ソラフェニブのロシア市場規模推移 ・ソラフェニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ソラフェニブの日本市場規模推移 ・ソラフェニブの中国市場規模推移 ・ソラフェニブの韓国市場規模推移 ・ソラフェニブのインド市場規模推移 ・ソラフェニブの東南アジア市場規模推移 ・ソラフェニブの南米市場分析（ブラジル、アルゼンチン等） ・ソラフェニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ソラフェニブの種類別分析/販売量、売上、市場シェア（カプセル、タブレット） ・ソラフェニブの用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・ソラフェニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ソラフェニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Sorafenib is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Sorafenib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Allergan
Alnylam Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Levolta Pharmaceuticals
Mabtech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Capsule
Tablet
Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sorafenib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sorafenib, with price, sales, revenue and global market share of Sorafenib in 2017 and 2018.
Chapter 3, the Sorafenib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sorafenib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Sorafenib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Sorafenib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Sorafenib Introduction
1.2 Market Analysis by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Sorafenib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Sorafenib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Alnylam Pharmaceuticals
2.3.1 Business Overview
2.3.2 Sorafenib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Acceleron Pharma
2.4.1 Business Overview
2.4.2 Sorafenib Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Acceleron Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Biocon
2.5.1 Business Overview
2.5.2 Sorafenib Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biocon Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bionomics
2.6.1 Business Overview
2.6.2 Sorafenib Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bionomics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 CASI Pharmaceuticals
2.7.1 Business Overview
2.7.2 Sorafenib Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CASI Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Sorafenib Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Enzon Pharmaceuticals
2.9.1 Business Overview
2.9.2 Sorafenib Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Enzon Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Five Prime Therapeutics
2.10.1 Business Overview
2.10.2 Sorafenib Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Five Prime Therapeutics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Fujifilm Kyowa Kirin Biologics
2.11.1 Business Overview
2.11.2 Sorafenib Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Fujifilm Kyowa Kirin Biologics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Genentech
2.12.1 Business Overview
2.12.2 Sorafenib Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Genentech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Genexine
2.13.1 Business Overview
2.13.2 Sorafenib Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Genexine Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Hetero Drugs
2.14.1 Business Overview
2.14.2 Sorafenib Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Hetero Drugs Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 ImClone Systems
2.15.1 Business Overview
2.15.2 Sorafenib Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 ImClone Systems Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Intas Pharmaceuticals
2.16.1 Business Overview
2.16.2 Sorafenib Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Intas Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Levolta Pharmaceuticals
2.17.1 Business Overview
2.17.2 Sorafenib Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Levolta Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Mabtech
2.18.1 Business Overview
2.18.2 Sorafenib Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Mabtech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Sorafenib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Sorafenib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Sorafenib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Sorafenib Manufacturer Market Share in 2018
3.3.2 Top 6 Sorafenib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Sorafenib Market Analysis by Regions
4.1 Global Sorafenib Sales, Revenue and Market Share by Regions
4.1.1 Global Sorafenib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Sorafenib Revenue and Market Share by Regions (2014-2019)
4.2 North America Sorafenib Sales and Growth Rate (2014-2019)
4.3 Europe Sorafenib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Sorafenib Sales and Growth Rate (2014-2019)
4.5 South America Sorafenib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Sorafenib Sales and Growth Rate (2014-2019)
5 North America Sorafenib by Country
5.1 North America Sorafenib Sales, Revenue and Market Share by Country
5.1.1 North America Sorafenib Sales and Market Share by Country (2014-2019)
5.1.2 North America Sorafenib Revenue and Market Share by Country (2014-2019)
5.2 United States Sorafenib Sales and Growth Rate (2014-2019)
5.3 Canada Sorafenib Sales and Growth Rate (2014-2019)
5.4 Mexico Sorafenib Sales and Growth Rate (2014-2019)
6 Europe Sorafenib by Country
6.1 Europe Sorafenib Sales, Revenue and Market Share by Country
6.1.1 Europe Sorafenib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Sorafenib Revenue and Market Share by Country (2014-2019)
6.2 Germany Sorafenib Sales and Growth Rate (2014-2019)
6.3 UK Sorafenib Sales and Growth Rate (2014-2019)
6.4 France Sorafenib Sales and Growth Rate (2014-2019)
6.5 Russia Sorafenib Sales and Growth Rate (2014-2019)
6.6 Italy Sorafenib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Sorafenib by Country
7.1 Asia-Pacific Sorafenib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Sorafenib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Sorafenib Revenue and Market Share by Country (2014-2019)
7.2 China Sorafenib Sales and Growth Rate (2014-2019)
7.3 Japan Sorafenib Sales and Growth Rate (2014-2019)
7.4 Korea Sorafenib Sales and Growth Rate (2014-2019)
7.5 India Sorafenib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Sorafenib Sales and Growth Rate (2014-2019)
8 South America Sorafenib by Country
8.1 South America Sorafenib Sales, Revenue and Market Share by Country
8.1.1 South America Sorafenib Sales and Market Share by Country (2014-2019)
8.1.2 South America Sorafenib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Sorafenib Sales and Growth Rate (2014-2019)
8.3 Argentina Sorafenib Sales and Growth Rate (2014-2019)
8.4 Colombia Sorafenib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Sorafenib by Countries
9.1 Middle East and Africa Sorafenib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Sorafenib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Sorafenib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Sorafenib Sales and Growth Rate (2014-2019)
9.3 Turkey Sorafenib Sales and Growth Rate (2014-2019)
9.4 Egypt Sorafenib Sales and Growth Rate (2014-2019)
9.5 Nigeria Sorafenib Sales and Growth Rate (2014-2019)
9.6 South Africa Sorafenib Sales and Growth Rate (2014-2019)
10 Global Sorafenib Market Segment by Type
10.1 Global Sorafenib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Sorafenib Sales and Market Share by Type (2014-2019)
10.1.2 Global Sorafenib Revenue and Market Share by Type (2014-2019)
10.2 Capsule Sales Growth and Price
10.2.1 Global Capsule Sales Growth (2014-2019)
10.2.2 Global Capsule Price (2014-2019)
10.3 Tablet Sales Growth and Price
10.3.1 Global Tablet Sales Growth (2014-2019)
10.3.2 Global Tablet Price (2014-2019)
11 Global Sorafenib Market Segment by Application
11.1 Global Sorafenib Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacy Sales Growth (2014-2019)
11.3 Retail Pharmacy Sales Growth (2014-2019)
11.4 Online Pharmacy Sales Growth (2014-2019)
12 Sorafenib Market Forecast (2019-2024)
12.1 Global Sorafenib Sales, Revenue and Growth Rate (2019-2024)
12.2 Sorafenib Market Forecast by Regions (2019-2024)
12.2.1 North America Sorafenib Market Forecast (2019-2024)
12.2.2 Europe Sorafenib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Sorafenib Market Forecast (2019-2024)
12.2.4 South America Sorafenib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Sorafenib Market Forecast (2019-2024)
12.3 Sorafenib Market Forecast by Type (2019-2024)
12.3.1 Global Sorafenib Sales Forecast by Type (2019-2024)
12.3.2 Global Sorafenib Market Share Forecast by Type (2019-2024)
12.4 Sorafenib Market Forecast by Application (2019-2024)
12.4.1 Global Sorafenib Sales Forecast by Application (2019-2024)
12.4.2 Global Sorafenib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Sorafenib Picture
Table Product Specifications of Sorafenib
Figure Global Sales Market Share of Sorafenib by Types in 2018
Table Sorafenib Types for Major Manufacturers
Figure Capsule Picture
Figure Tablet Picture
Figure Sorafenib Sales Market Share by Applications in 2018
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Figure United States Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure France Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure China Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure India Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Sorafenib Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Sorafenib Type and Applications
Table Pfizer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Sorafenib Type and Applications
Table Allergan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals Sorafenib Type and Applications
Table Alnylam Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Acceleron Pharma Basic Information, Manufacturing Base and Competitors
Table Acceleron Pharma Sorafenib Type and Applications
Table Acceleron Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Sorafenib Type and Applications
Table Biocon Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bionomics Basic Information, Manufacturing Base and Competitors
Table Bionomics Sorafenib Type and Applications
Table Bionomics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CASI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table CASI Pharmaceuticals Sorafenib Type and Applications
Table CASI Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Sorafenib Type and Applications
Table Celgene Corporation Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Enzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Enzon Pharmaceuticals Sorafenib Type and Applications
Table Enzon Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Five Prime Therapeutics Basic Information, Manufacturing Base and Competitors
Table Five Prime Therapeutics Sorafenib Type and Applications
Table Five Prime Therapeutics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base and Competitors
Table Fujifilm Kyowa Kirin Biologics Sorafenib Type and Applications
Table Fujifilm Kyowa Kirin Biologics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Sorafenib Type and Applications
Table Genentech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Genexine Basic Information, Manufacturing Base and Competitors
Table Genexine Sorafenib Type and Applications
Table Genexine Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs Sorafenib Type and Applications
Table Hetero Drugs Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ImClone Systems Basic Information, Manufacturing Base and Competitors
Table ImClone Systems Sorafenib Type and Applications
Table ImClone Systems Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Sorafenib Type and Applications
Table Intas Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Levolta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Levolta Pharmaceuticals Sorafenib Type and Applications
Table Levolta Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mabtech Basic Information, Manufacturing Base and Competitors
Table Mabtech Sorafenib Type and Applications
Table Mabtech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Sorafenib Sales by Manufacturer (2017-2018)
Figure Global Sorafenib Sales Market Share by Manufacturer in 2017
Figure Global Sorafenib Sales Market Share by Manufacturer in 2018
Table Global Sorafenib Revenue by Manufacturer (2017-2018)
Figure Global Sorafenib Revenue Market Share by Manufacturer in 2017
Figure Global Sorafenib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Sorafenib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Sorafenib Manufacturer (Revenue) Market Share in 2018
Figure Global Sorafenib Sales and Growth Rate (2014-2019)
Figure Global Sorafenib Revenue and Growth Rate (2014-2019)
Table Global Sorafenib Sales by Regions (2014-2019)
Table Global Sorafenib Sales Market Share by Regions (2014-2019)
Table Global Sorafenib Revenue by Regions (2014-2019)
Figure Global Sorafenib Revenue Market Share by Regions in 2014
Figure Global Sorafenib Revenue Market Share by Regions in 2018
Figure North America Sorafenib Sales and Growth Rate (2014-2019)
Figure Europe Sorafenib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Sorafenib Sales and Growth Rate (2014-2019)
Figure South America Sorafenib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Sorafenib Sales and Growth Rate (2014-2019)
Figure North America Sorafenib Revenue and Growth Rate (2014-2019)
Table North America Sorafenib Sales by Countries (2014-2019)
Table North America Sorafenib Sales Market Share by Countries (2014-2019)
Figure North America Sorafenib Sales Market Share by Countries in 2014
Figure North America Sorafenib Sales Market Share by Countries in 2018
Table North America Sorafenib Revenue by Countries (2014-2019)
Table North America Sorafenib Revenue Market Share by Countries (2014-2019)
Figure North America Sorafenib Revenue Market Share by Countries in 2014
Figure North America Sorafenib Revenue Market Share by Countries in 2018
Figure United States Sorafenib Sales and Growth Rate (2014-2019)
Figure Canada Sorafenib Sales and Growth Rate (2014-2019)
Figure Mexico Sorafenib Sales and Growth Rate (2014-2019)
Figure Europe Sorafenib Revenue and Growth Rate (2014-2019)
Table Europe Sorafenib Sales by Countries (2014-2019)
Table Europe Sorafenib Sales Market Share by Countries (2014-2019)
Table Europe Sorafenib Revenue by Countries (2014-2019)
Figure Europe Sorafenib Revenue Market Share by Countries in 2017
Figure Europe Sorafenib Revenue Market Share by Countries in 2018
Figure Germany Sorafenib Sales and Growth Rate (2014-2019)
Figure UK Sorafenib Sales and Growth Rate (2014-2019)
Figure France Sorafenib Sales and Growth Rate (2014-2019)
Figure Russia Sorafenib Sales and Growth Rate (2014-2019)
Figure Italy Sorafenib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Sorafenib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Sorafenib Sales by Countries (2014-2019)
Table Asia-Pacific Sorafenib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Sorafenib Sales Market Share by Countries 2018
Table Asia-Pacific Sorafenib Revenue by Countries (2014-2019)
Figure Asia-Pacific Sorafenib Revenue Market Share by Countries 2018
Figure China Sorafenib Sales and Growth Rate (2014-2019)
Figure Japan Sorafenib Sales and Growth Rate (2014-2019)
Figure Korea Sorafenib Sales and Growth Rate (2014-2019)
Figure India Sorafenib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Sorafenib Sales and Growth Rate (2014-2019)
Figure South America Sorafenib Revenue and Growth Rate (2014-2019)
Table South America Sorafenib Sales by Countries (2014-2019)
Table South America Sorafenib Sales Market Share by Countries (2014-2019)
Figure South America Sorafenib Sales Market Share by Countries in 2018
Table South America Sorafenib Revenue by Countries (2014-2019)
Table South America Sorafenib Revenue Market Share by Countries (2014-2019)
Figure South America Sorafenib Revenue Market Share by Countries in 2018
Figure Brazil Sorafenib Sales and Growth Rate (2014-2019)
Figure Argentina Sorafenib Sales and Growth Rate (2014-2019)
Figure Colombia Sorafenib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Sorafenib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Sorafenib Sales by Countries (2014-2019)
Table Middle East and Africa Sorafenib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Sorafenib Sales Market Share by Countries in 2018
Table Middle East and Africa Sorafenib Revenue by Countries (2014-2019)
Table Middle East and Africa Sorafenib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Sorafenib Revenue Market Share by Countries in 2014
Figure Middle East and Africa Sorafenib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Sorafenib Sales and Growth Rate (2014-2019)
Figure UAE Sorafenib Sales and Growth Rate (2014-2019)
Figure Egypt Sorafenib Sales and Growth Rate (2014-2019)
Figure Nigeria Sorafenib Sales and Growth Rate (2014-2019)
Figure South Africa Sorafenib Sales and Growth Rate (2014-2019)
Table Global Sorafenib Sales by Type (2014-2019)
Table Global Sorafenib Sales Share by Type (2014-2019)
Table Global Sorafenib Revenue by Type (2014-2019)
Table Global Sorafenib Revenue Share by Type (2014-2019)
Figure Global Capsule Sales Growth (2014-2019)
Figure Global Capsule Price (2014-2019)
Figure Global Tablet Sales Growth (2014-2019)
Figure Global Tablet Price (2014-2019)
Table Global Sorafenib Sales by Application (2014-2019)
Table Global Sorafenib Sales Share by Application (2014-2019)
Figure Global Retail Pharmacy Sales Growth (2014-2019)
Figure Global Online Pharmacy Sales Growth (2014-2019)
Figure Global Sorafenib Sales, Revenue and Growth Rate (2019-2024)
Table Global Sorafenib Sales Forecast by Regions (2019-2024)
Table Global Sorafenib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Sorafenib Market Forecast (2019-2024)
Figure Europe Sales Sorafenib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Sorafenib Market Forecast (2019-2024)
Figure South America Sales Sorafenib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Sorafenib Market Forecast (2019-2024)
Table Global Sorafenib Sales Forecast by Type (2019-2024)
Table Global Sorafenib Market Share Forecast by Type (2019-2024)
Table Global Sorafenib Sales Forecast by Application (2019-2024)
Table Global Sorafenib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
アモキシシリンナトリウムの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Amoxicillin Sodium is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Amoxicillin Sodium in global m…- 中央充填薬局自動化システムの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Central Fill Pharmacy Automation System market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- アモキシシリンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Amoxicillin is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Amoxicillin in global market, especia…
- 世界の薬局再梱包システム市場2019 The global Pharmacy Repackaging System market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Pharmacy Repackaging System market status and forecast, categorizes the global Pharmacy Repackaging Sys…
- 世界の薬局の小売り市場：市場規模・現状・予測 Pharmacy Retailing is drugs sold in the retail and bought on the internet, not in the hospital.The global average gross margin of pharmacy retailing is in the fluctuation trend, from 12.35% in 2011 to 11.58% in 2015. With the situation of global economy, gross margin will be in decreasing trend in t…